# Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

> **NCT05664126** · PHASE2 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 42 (estimated)

## Conditions studied

- Cytomegalovirus
- Adenovirus

## Interventions

- **DRUG:** VST infusion
- **DEVICE:** CliniMACS

## Key facts

- **NCT ID:** NCT05664126
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664126, "Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05664126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*